Application
Reactant for the synthesis of: Ruthenium(II)-Hmtpo complexes Dihydroorotate dehydrogenase inhibitors with antimalarial activityReactant for the Vilsmeier reaction of conjugated carbocycles and heterocyclesInvestigations of the pharmacological activity caused by binding to HIV TAR RNAAdditive to study the space charge layer in silver bromide microcrystals
Caution
Please find SDS provided by EDQM here..
General description
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
Other Notes
Sales restrictions may apply.
Packaging
Unit quantity: 20 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
This product has met the following criteria to qualify for the following awards: